Literature DB >> 8425300

Flecainide-induced arrhythmia in canine ventricular epicardium. Phase 2 reentry?

S C Krishnan1, C Antzelevitch.   

Abstract

BACKGROUND: We recently reported that sodium channel block can produce opposite effects on action potential duration (APD) and refractoriness in epicardial versus endocardial tissues of the canine ventricle. In addition, strong sodium channel current inhibition was found to cause loss of the action potential dome in epicardium but not endocardium, thus inducing a marked dispersion of repolarization and refractoriness between epicardium and endocardium as well as among neighboring epicardial sites. The marked heterogeneity that evolves under these conditions provides a substrate for the development of arrhythmias. Flecainide was found to induce extrasystolic activity more readily than other sodium blockers. The present study contrasts the electrophysiological actions of flecainide in canine ventricular epicardium and endocardium and examines the characteristics of flecainide-induced arrhythmias in epicardial sheets of canine ventricle. METHODS AND
RESULTS: Standard microelectrode techniques were used. Flecainide (10-20 microM) produced either prolongation or marked abbreviation of APD in epicardium but only minor changes in the APD of endocardium. Marked abbreviation of APD in epicardium was due to loss of the action potential dome (plateau phase). Arrhythmias displaying characteristics of reentry could be readily induced in flecainide-treated preparations either by increasing the stimulation rate or by introduction of extrastimuli. Flecainide-induced slowing of conduction, more accentuated at the faster stimulation rates, appeared to act synergistically with the drug-induced dispersion of repolarization to generate reentry in these relatively small sheets of epicardium. 4-Aminopyridine, a transient outward current (Ito) blocker, reversed the flecainide-induced marked abbreviation of APD in epicardium and abolished reentrant activity in all cases. Flecainide failed to induce reentry in preparations pretreated with 4-aminopyridine.
CONCLUSIONS: Our data suggest that the presence of a prominent Ito in epicardium contributes the development of marked electrical heterogeneity in the ventricle after exposure to flecainide. Flecainide-induced dispersion of repolarization, especially when accompanied by prominent conduction delays, results in extrasystolic activity via a mechanism that we have termed "phase 2 reentry." Our results also suggest a role for Ito blockers in the treatment of reentrant arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425300     DOI: 10.1161/01.cir.87.2.562

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  40 in total

1.  Cardiac devices with class 1C antiarrhythmics: a potentially toxic combination.

Authors:  Andrew Apps; Charles Philip Miller; Sarah Fellows; Michael Jones
Journal:  BMJ Case Rep       Date:  2015-08-18

Review 2.  ECG repolarization waves: their genesis and clinical implications.

Authors:  Thinn Hlaing; Tara DiMino; Peter R Kowey; Gan-Xin Yan
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-04       Impact factor: 1.468

3.  In vivo human demonstration of phase 2 reentry.

Authors:  Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2005-08       Impact factor: 6.343

4.  Cellular mechanism and arrhythmogenic potential of T-wave alternans in the Brugada syndrome.

Authors:  Jeffrey M Fish; Charles Antzelevitch
Journal:  J Cardiovasc Electrophysiol       Date:  2007-11-21

Review 5.  Drug-induced spatial dispersion of repolarization.

Authors:  Charles Antzelevitch
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

Review 6.  J wave syndromes.

Authors:  Charles Antzelevitch; Gan-Xin Yan
Journal:  Heart Rhythm       Date:  2009-12-11       Impact factor: 6.343

Review 7.  Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channel.

Authors:  Carlo Napolitano; Charles Antzelevitch
Journal:  Circ Res       Date:  2011-03-04       Impact factor: 17.367

Review 8.  Can antiarrhythmic agents be selected based on mechanism of action?

Authors:  W Lau; D Newman; P Dorian
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

9.  Selective gamma-ketoaldehyde scavengers protect Nav1.5 from oxidant-induced inactivation.

Authors:  T Nakajima; S S Davies; E Matafonova; F Potet; V Amarnath; K A Tallman; R A Serwa; N A Porter; J R Balser; S Kupershmidt; L J Roberts
Journal:  J Mol Cell Cardiol       Date:  2009-12-03       Impact factor: 5.000

Review 10.  Clinical use of and future perspectives on antiarrhythmic drugs.

Authors:  Juan Carlos Estrada; Dawood Darbar
Journal:  Eur J Clin Pharmacol       Date:  2008-09-02       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.